The Bone Marrow Microenvironment in Waldenström Macroglobulinemia

Shahrzad Jalali, Stephen Maxted Ansell

Research output: Contribution to journalArticle

Abstract

Waldenström macroglobulinemia (WM) is an indolent B-cell lymphoma defined predominantly by infiltration of lymphoplasmacytic cells into the bone marrow (BM) and increased production of monoclonal immunoglobulin M (IgM) by lymphoplasmacytic cells, and the secretion of IgM is enhanced by cytokines in the bone marrow microenvironment. This article highlights the available data regarding the interaction of WM cells with both the cellular and noncellular compartments of the BM microenvironment and discusses how the BM promotes malignant cell growth and increases IgM production in this disease.

Original languageEnglish (US)
JournalHematology/Oncology Clinics of North America
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Waldenstrom Macroglobulinemia
Immunoglobulin M
Bone Marrow
B-Cell Lymphoma
Bone Marrow Cells
Cytokines
Growth

Keywords

  • Angiogenesis
  • Bone marrow niche
  • Cytokines
  • Homing
  • Immune cells
  • Microenvironment
  • Waldenström macroglobulinemia

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

The Bone Marrow Microenvironment in Waldenström Macroglobulinemia. / Jalali, Shahrzad; Ansell, Stephen Maxted.

In: Hematology/Oncology Clinics of North America, 01.01.2018.

Research output: Contribution to journalArticle

@article{13e0cbc9dfcc48a197a3e008fd1f604a,
title = "The Bone Marrow Microenvironment in Waldenstr{\"o}m Macroglobulinemia",
abstract = "Waldenstr{\"o}m macroglobulinemia (WM) is an indolent B-cell lymphoma defined predominantly by infiltration of lymphoplasmacytic cells into the bone marrow (BM) and increased production of monoclonal immunoglobulin M (IgM) by lymphoplasmacytic cells, and the secretion of IgM is enhanced by cytokines in the bone marrow microenvironment. This article highlights the available data regarding the interaction of WM cells with both the cellular and noncellular compartments of the BM microenvironment and discusses how the BM promotes malignant cell growth and increases IgM production in this disease.",
keywords = "Angiogenesis, Bone marrow niche, Cytokines, Homing, Immune cells, Microenvironment, Waldenstr{\"o}m macroglobulinemia",
author = "Shahrzad Jalali and Ansell, {Stephen Maxted}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.hoc.2018.05.005",
language = "English (US)",
journal = "Hematology/Oncology Clinics of North America",
issn = "0889-8588",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - The Bone Marrow Microenvironment in Waldenström Macroglobulinemia

AU - Jalali, Shahrzad

AU - Ansell, Stephen Maxted

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Waldenström macroglobulinemia (WM) is an indolent B-cell lymphoma defined predominantly by infiltration of lymphoplasmacytic cells into the bone marrow (BM) and increased production of monoclonal immunoglobulin M (IgM) by lymphoplasmacytic cells, and the secretion of IgM is enhanced by cytokines in the bone marrow microenvironment. This article highlights the available data regarding the interaction of WM cells with both the cellular and noncellular compartments of the BM microenvironment and discusses how the BM promotes malignant cell growth and increases IgM production in this disease.

AB - Waldenström macroglobulinemia (WM) is an indolent B-cell lymphoma defined predominantly by infiltration of lymphoplasmacytic cells into the bone marrow (BM) and increased production of monoclonal immunoglobulin M (IgM) by lymphoplasmacytic cells, and the secretion of IgM is enhanced by cytokines in the bone marrow microenvironment. This article highlights the available data regarding the interaction of WM cells with both the cellular and noncellular compartments of the BM microenvironment and discusses how the BM promotes malignant cell growth and increases IgM production in this disease.

KW - Angiogenesis

KW - Bone marrow niche

KW - Cytokines

KW - Homing

KW - Immune cells

KW - Microenvironment

KW - Waldenström macroglobulinemia

UR - http://www.scopus.com/inward/record.url?scp=85050369372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050369372&partnerID=8YFLogxK

U2 - 10.1016/j.hoc.2018.05.005

DO - 10.1016/j.hoc.2018.05.005

M3 - Article

C2 - 30190017

AN - SCOPUS:85050369372

JO - Hematology/Oncology Clinics of North America

JF - Hematology/Oncology Clinics of North America

SN - 0889-8588

ER -